Table 2.
Intake surgeon | Intake research nurse | Informed consent | Surgery | Follow-up 2 weeks | Follow-up 4 weeks | Follow-up 8 weeks | Follow-up 12 weeks | Follow-up 26 weeks | Follow-up 52 weeks | Follow-up 104 weeks | Follow-up 156 weeks | Follow-up 208 weeks | Follow-up 260 weeks | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Visit | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |||||
Inclusion/exclusion criteria | X | |||||||||||||
Informed consent | X | |||||||||||||
Treatment preference | X | X | ||||||||||||
Expected recovery | X | X | ||||||||||||
Demographics & diagnosis | X | X | ||||||||||||
Basic physical examination | X | |||||||||||||
Neurological examination | X | X | X | X | X | X | X | X | ||||||
Randomisation | X | |||||||||||||
Dynamic X-ray | X | X | X | X | X | X | X | |||||||
MRI | X | X | X | |||||||||||
CT | X | X | X | |||||||||||
NDI | X | X | X | X | X | X | X | X | X | X | X | |||
McGill | X | X | X | X | X | X | X | X | X | X | X | |||
VAS arm and neck | X | X | X | X | X | X | X | X | X | X | X | |||
SF-36 | X | X | X | X | X | X | X | X | X | X | X | |||
HADS | X | X | X | X | X | X | X | X | ||||||
Karasek | X | X | X | X | X | X | X | X | X | X | X | |||
Likert | X | X | X | X | X | X | X | X | X | X | ||||
Macnab | X | X | X | X | X | |||||||||
EuroQol and VAS | X | X | X | X | X | X | X | X | X | X | X | |||
Cost diaries | X | X | X | X | X | X | X | |||||||
Complications | X | X | X | X | X | X | X | |||||||
Re-operation | X | X | X | X | X | X |